摘要
目的:研究抑制胞浆型磷脂酶A2(cPLA2)对表皮生长因子(EGF)和胎牛血清(FBS)诱导Hela细胞增殖及cPLA2活性和蛋白表达的影响。方法:采用cPLA2特异性抑制剂AACOCF3、反义寡核苷酸(SK7111)及其上游酶ERK1/2抑制剂U0126,分别作用于Hela细胞,观察在EGF及FBS作用下Hela细胞增殖以及细胞周期的变化;采用cPLA2活性检测盒及Western blot检测cPLA2活性及表达。结果:AACOCF3、SK7111及U0126均能明显抑制cPLA2活性,且呈剂量依赖性地抑制EGF和FBS诱导的Hela细胞增殖,尤以SK7111作用最为明显;流式细胞仪检测细胞周期表明,AACOCF3和U0126可将Hela细胞阻滞在S期。结论:cPLA2选择性抑制剂及其反义寡核苷酸可通过抑制cPLA2活性显著抑制EGF和FBS诱导Hela细胞增殖,同时,ERK1/2在此过程中可能具有调节作用。
Objective:To explore effects of cytosoloic phospholipase A2(cPLA2) on epidermal growth factor(EGF) induced and fetal bovine serum(FBS) induced Hela cells proliferation and its activity and expression.Methods:We used inhibitor AACOCF3 and antisense oligodeoxynucleotide(ODN) of cPLA2,and inhibitor U0126 of ERK1/2 to inhibit cPLA2 activity and expression,and observed the changes of Hela cells viabilities and cell cycle by CellTiter-Blue and flow cytometry.Meanwhile,cPLA2 activity and expression were also detected by cPLA2 activity assay kit and western blot.Results:Both inhibitor and antisense ODN of cPLA2 suppressed activity of cPLA2,and obviously inhibited the proliferation induced by EGF and FBS in dose-dependent manner in Hela cells.Both inhibitors of cPLA2 and ERK1/2 decreased cell proportion of G2/M obviously,and they blocked Hela at the S/G2 boundary.Moreover,the inhibitory effect on Hela cells proliferation of antisense ODN was most obvious and the inhibitory effect on cPLA2 protein expression was in a dose-dependent manner.The similar situation of ERK1/2 inhibitor was observed.Conclusion:cPLA2 could play important roles in EGF- and FBS-induced Hela cells proliferation,and ERK1/2 probably contribute to regulation on this course.
出处
《临床肿瘤学杂志》
CAS
2008年第10期865-870,共6页
Chinese Clinical Oncology
关键词
胞浆型磷脂酶A2
宫颈癌
增殖
表皮生长因子
细胞周期
Cytosolic phospholipase A2
Cervical cancer
Proliferation
Epidermal growth factor
Cell cycle